Thymulin 20mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only — not for human or veterinary use.

Product Overview

Thymulin is a synthetic thymic peptide studied in controlled laboratory environments for its involvement in immune-regulatory signalling pathways and thymus-associated biochemical modelling. This lyophilized 20 mg preparation is supplied in a sealed research vial and supports reproducible in vitro experimentation.

Peptide Overview

Thymulin has been incorporated into research models examining thymic peptide behaviour, immune signalling communication and regulatory pathway dynamics. Its defined molecular structure and stability profile make it suitable for comparative peptide evaluation under controlled experimental conditions.

Scientific Context

Research into thymus-derived peptides expanded significantly during the late twentieth century as laboratories investigated endogenous regulatory mechanisms governing immune-system signalling. Thymulin has since been utilised within experimental frameworks exploring peptide-mediated modulation of immune communication pathways and receptor-interaction dynamics.

Mechanistic Focus in Research

• Thymic peptide signalling pathway modelling
• Immune-regulatory interaction research
• Peptide–receptor communication analysis
• Comparative structure–function evaluation
• Controlled in vitro biochemical investigations

Analytical Verification (COA)

Independent Liquilabs analysis confirms validation for Batch GF-THYMU20-B241. Key analytical results include:

• Assay Content: 20.299 mg
• Identification – Retention Time: 0.994
• Identification – Spectrum: 991
• Purity: greater than 99.8 percent
• Bioburden: not detected
• Endotoxins: less than 0.001 EU per mg
• Heavy Metals: not detected including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium

All analytical values were obtained using validated chromatographic, spectroscopic and microbiological procedures. Results relate only to the tested batch sample.

Research Applications

• Immune signalling and thymic pathway research
• Regulatory peptide interaction modelling
• Comparative immune-peptide evaluation
• Cellular communication studies
• Controlled laboratory investigations

Grail Formula Quality

Every Grail Formula research peptide undergoes independent third-party laboratory testing for identity, assay accuracy, purity and microbial safety. Each batch is verified for analytical consistency and reproducibility to support reliable scientific research outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptide materials with batch-number traceability and sealed-vial integrity. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment
• Supplied for human investigational use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 20.299 mg
Purity greater than 99.8 percent
Retention time and spectral identity confirmation
Endotoxin levels below 0.001 EU per mg
No detectable microbial contamination
No detectable heavy metals
EU shipments include bacteriostatic water
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.